Navigation Links
Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine Comes to the App Store
Date:8/3/2011

PHILADELPHIA, August 3, 2011 /PRNewswire/ --


- Content From the Widely-respected Cardiology Reference Book's Forthcoming Ninth Edition Now Available to Users on iPad, iPhone and iPod Touch


Elsevier, the leading provider of scientific, technical and medical information products and services, announced its Braunwald's Heart Disease Practice Guides App for iPad, iPhone and iPod Touch is now available on the App Store. The app includes content from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, Ninth Edition, and provides the most up-to-date, evidence-based cardiology clinical practice guidelines from the American College of Cardiology (ACC) and the American Heart Association (AHA).

Braunwald's Heart Disease Practice Guidelines App provides access to the most useful, clinically actionable and evidence-based cardiology clinical practice guidelines today. The joint cardiovascular practice guidelines of the ACC and the AHA have become important documents for guiding cardiology practice and establishing benchmarks for quality of care. In each edition of Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, the market-leading global clinical textbook of cardiology, authors and editors summarize all the latest ACC/AHA practice guidelines and transform them into clinically actionable points presented in an easily accessible, bulleted format. For the first time the guidelines have been streamlined for mobile presentation and are available for download by cardiologists and all related healthcare professionals who want mobile access to this clinically actionable information in a high-yield, bulleted format.

"We wanted to provide cardiologists and healthcare professionals the ability to have the most up-to-date information available right at their fingertips," said Dr. Eugene Braunwald, founding editor and online editor of Braunwald's Heart Disease.  "This app will give clinicians and professionals anytime, anywhere access to this important information so they can continue to provide the best quality of care possible for their patients."

Braunwald's Heart Disease Practice Guidelines App has several features, including:

  • Content from the brand-new, ninth edition of Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine;
  • Content and cases based on the latest published evidence;
  • Clinically actionable points presented in an easily-digested, bulleted format;
  • Easy navigation, searching and browsing options.


Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, Ninth Edition features definitive, state-of-the-art answers covering every aspect of contemporary cardiology.  Edited by Drs. Robert Bonow, Douglas Mann, Douglas Zipes, and Peter Libby, the reference applies the most recent knowledge in molecular biology and genetics, imaging, pharmacology, interventional cardiology, electrophysiology, and much more. Additionally, the new edition features online content, including new dynamic cardiac imaging videos, heart sound recordings, and podcasts.

The Braunwald's Heart Disease Practice Guidelines App is available for $24.99 from the App Store on iPad, iPhone and iPod touch, or at http://www.itunes.com/appstore .

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).


Media contact
Tom Reller
Vice President Global Corporate Relations, Elsevier
+1-212-462-1912
t.reller@elsevier.com




'/>"/>
SOURCE Elsevier
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartWare to Report Financial Results for Second Quarter of 2011
2. German Patient Surpasses 5 Years of Support on DuraHeart™ Left Ventricular Assist Device
3. TandemHeart Approved for Expanded Reimbursement
4. Cardiac Science Gains Japanese Regulatory Approval for Powerheart AED
5. CardioFocus HeartLight™ Endoscopic Ablation System Enables Treatment of Atrial Fibrillation: Live Case and Abstract Presented at EHRA EUROPACE 2011
6. New Study Shows Viability of Heart Pumps for Older Heart-Failure Patients
7. Analysis Finds BYETTA® Associated with Lower Likelihood of Heart Failure Compared with Other Diabetes Therapies: Results Presented at ADA 2011
8. Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation
9. CardioFocus HeartLight™ Endoscopic Ablation System to be Featured at EHRA EUROPACE 2011
10. Franciscan St. Francis Heart Center Surgeon Pioneers Use of Heart Valve Repair Ring
11. HeartWare to Present at the Wells Fargo 2011 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):